310 related articles for article (PubMed ID: 23647931)
21. Modeling dynamic changes in type 1 diabetes progression: quantifying beta-cell variation after the appearance of islet-specific autoimmune responses.
Nelson P; Smith N; Ciupe S; Zou W; Omenn GS; Pietropaolo M
Math Biosci Eng; 2009 Oct; 6(4):753-78. PubMed ID: 19835428
[TBL] [Abstract][Full Text] [Related]
22. Ectopic PDX-1 expression in liver ameliorates type 1 diabetes.
Shternhall-Ron K; Quintana FJ; Perl S; Meivar-Levy I; Barshack I; Cohen IR; Ferber S
J Autoimmun; 2007; 28(2-3):134-42. PubMed ID: 17383157
[TBL] [Abstract][Full Text] [Related]
23. β-Cell responses to nitric oxide.
Broniowska KA; Oleson BJ; Corbett JA
Vitam Horm; 2014; 95():299-322. PubMed ID: 24559923
[TBL] [Abstract][Full Text] [Related]
24. The role of endoplasmic reticulum stress in autoimmune-mediated beta-cell destruction in type 1 diabetes.
Zhong J; Rao X; Xu JF; Yang P; Wang CY
Exp Diabetes Res; 2012; 2012():238980. PubMed ID: 22454627
[TBL] [Abstract][Full Text] [Related]
25. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes.
Brezar V; Carel JC; Boitard C; Mallone R
Endocr Rev; 2011 Oct; 32(5):623-69. PubMed ID: 21700723
[TBL] [Abstract][Full Text] [Related]
26. Partners in Crime: Beta-Cells and Autoimmune Responses Complicit in Type 1 Diabetes Pathogenesis.
Toren E; Burnette KS; Banerjee RR; Hunter CS; Tse HM
Front Immunol; 2021; 12():756548. PubMed ID: 34691077
[TBL] [Abstract][Full Text] [Related]
27. Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus.
Barcala Tabarrozzi AE; Castro CN; Dewey RA; Sogayar MC; Labriola L; Perone MJ
Clin Exp Immunol; 2013 Feb; 171(2):135-46. PubMed ID: 23286940
[TBL] [Abstract][Full Text] [Related]
28. Potential Mimicry of Viral and Pancreatic β Cell Antigens Through Non-Spliced and
Mishto M; Mansurkhodzhaev A; Rodriguez-Calvo T; Liepe J
Front Immunol; 2021; 12():656451. PubMed ID: 33936085
[TBL] [Abstract][Full Text] [Related]
29. The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives.
Luce S; Briet C; Bécourt C; Lemonnier F; Boitard C
Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():89-97. PubMed ID: 24003925
[TBL] [Abstract][Full Text] [Related]
30. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.
Pearson JA; Wong FS; Wen L
J Autoimmun; 2016 Jan; 66():76-88. PubMed ID: 26403950
[TBL] [Abstract][Full Text] [Related]
31. Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse.
Vukkadapu SS; Belli JM; Ishii K; Jegga AG; Hutton JJ; Aronow BJ; Katz JD
Physiol Genomics; 2005 Apr; 21(2):201-11. PubMed ID: 15671250
[TBL] [Abstract][Full Text] [Related]
32. How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.
Vives-Pi M; Rodríguez-Fernández S; Pujol-Autonell I
Apoptosis; 2015 Mar; 20(3):263-72. PubMed ID: 25604067
[TBL] [Abstract][Full Text] [Related]
33. Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?).
Roep BO; Thomaidou S; van Tienhoven R; Zaldumbide A
Nat Rev Endocrinol; 2021 Mar; 17(3):150-161. PubMed ID: 33293704
[TBL] [Abstract][Full Text] [Related]
34. Reduced CD4+ T-cell-specific gene expression in human type 1 diabetes mellitus.
Orban T; Kis J; Szereday L; Engelmann P; Farkas K; Jalahej H; Treszl A
J Autoimmun; 2007 Jun; 28(4):177-87. PubMed ID: 17320348
[TBL] [Abstract][Full Text] [Related]
35. Endoplasmic Reticulum-Mitochondria Crosstalk and Beta-Cell Destruction in Type 1 Diabetes.
Vig S; Lambooij JM; Zaldumbide A; Guigas B
Front Immunol; 2021; 12():669492. PubMed ID: 33936111
[TBL] [Abstract][Full Text] [Related]
36. Circulating β cell-specific CD8
Yeo L; Pujol-Autonell I; Baptista R; Eichmann M; Kronenberg-Versteeg D; Heck S; Dolton G; Sewell AK; Härkönen T; Mikk ML; Toppari J; Veijola R; Knip M; Ilonen J; Peakman M
Clin Exp Immunol; 2020 Mar; 199(3):263-277. PubMed ID: 31660582
[TBL] [Abstract][Full Text] [Related]
37. Unraveling the contribution of pancreatic beta-cell suicide in autoimmune type 1 diabetes.
Jaberi-Douraki M; Schnell S; Pietropaolo M; Khadra A
J Theor Biol; 2015 Jun; 375():77-87. PubMed ID: 24831415
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of the Keap1/Nrf2 Signaling Pathway Significantly Promotes the Progression of Type 1 Diabetes Mellitus.
Lou Y; Kong M; Li L; Hu Y; Zhai W; Qi X; Liu Z; Wu J
Oxid Med Cell Longev; 2021; 2021():7866720. PubMed ID: 33628382
[TBL] [Abstract][Full Text] [Related]
39. Type I interferons as key players in pancreatic β-cell dysfunction in type 1 diabetes.
Marroqui L; Perez-Serna AA; Babiloni-Chust I; Dos Santos RS
Int Rev Cell Mol Biol; 2021; 359():1-80. PubMed ID: 33832648
[TBL] [Abstract][Full Text] [Related]
40. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.
Christen U; Kimmel R
Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
